ACRS
Aclaris Therapeutics, Inc. · Healthcare · Biotechnology
Señales de momentum (gestores comparables): amplitud de titulares 0.0% · flujo de acciones +5.3% · nuevas posiciones netas 0.0% — fórmula
Todas las cifras de propiedad: únicamente gestores 13F seguidos, posiciones en acciones ordinarias, período de referencia Q2 2025
| Trimestre | Titulares | Δ | Acciones | Valor declarado | Nuevo | Cierres |
|---|---|---|---|---|---|---|
| Q2 2026 | 61 | -2 | 42.13M | $222.66M | +3 | −5 |
| Q1 2026 | 65 | -2 | 41.75M | $156.42M | +5 | −7 |
| Q4 2025 | 67 | +2 | 40.44M | $121.72M | +2 | — |
| Q3 2025 | 17 | +1 | 36.82M | $69.96M | +1 | — |
| Q2 2025 | 13 | 0 | 38.17M | $54.21M | — | — |
| Q1 2025 | 10 | 0 | 23.63M | $36.15M | — | — |
| Q4 2024 | 10 | +2 | 20.49M | $50.82M | +2 | — |
| Q3 2024 | 7 | -1 | 10.01M | $11.51M | — | −1 |
| Q2 2024 | 8 | — | 10.87M | $11.95M | — | — |
| # | Gestor | Acciones | Δ acciones | Valor | Su ponderación | Mantenida | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Adage Capital Partners ✦ | 9.63M | 0.0% | $13.67M | 0.0% | Held | 3 | SEC ↗ |
| 2 | The Vanguard Group ✦ (pasivo) | 6.66M | — | $9.46M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | The Vanguard Group ✦ (pasivo) | 6.66M | — | $9.46M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | The Vanguard Group ✦ (pasivo) | 6.66M | — | $9.46M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | BlackRock ✦ (pasivo) | 5.51M | — | $7.83M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | BlackRock ✦ (pasivo) | 5.51M | — | $7.83M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | BlackRock ✦ (pasivo) | 5.51M | — | $7.83M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | BlackRock ✦ (pasivo) | 5.51M | — | $7.83M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | BlackRock ✦ (pasivo) | 5.51M | — | $7.83M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | BlackRock ✦ (pasivo) | 5.51M | — | $7.83M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | BlackRock ✦ (pasivo) | 5.51M | — | $7.83M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | Millennium Management ✦ | 3.84M | -7.2% | $5.45M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 13 | D. E. Shaw & Co. ✦ | 2.80M | -4.9% | $3.98M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 14 | D. E. Shaw & Co. ✦ | 2.80M | -4.9% | $3.98M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 15 | Geode Capital Management ✦ (pasivo) | 2.46M | +108.4% | $3.50M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 16 | Geode Capital Management ✦ (pasivo) | 2.46M | +108.4% | $3.50M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 17 | Marshall Wace ✦ | 2.29M | -0.9% | $3.26M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 18 | Marshall Wace ✦ | 2.29M | -0.9% | $3.26M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 19 | Renaissance Technologies ✦ | 1.46M | +54.0% | $2.08M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 20 | Citadel Advisors ✦ | 1.14M | +1.9% | $1.62M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 21 | Citadel Advisors ✦ | 1.14M | +1.9% | $1.62M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 22 | State Street Global Advisors ✦ (pasivo) | 1.01M | +147.1% | $1.43M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 23 | Two Sigma Investments ✦ | 749.66K | -8.6% | $1.06M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 24 | Fidelity (FMR) ✦ | 442.25K | — | $627,991 | 0.0% | n/c | 1 | SEC ↗ |
| 25 | Fidelity (FMR) ✦ | 442.25K | — | $627,991 | 0.0% | n/c | 1 | SEC ↗ |
| 26 | T. Rowe Price ✦ | 166.37K | +35.1% | $237,000 | 0.0% | ▲ Add | 5 | SEC ↗ |
«Su ponderación» = la participación de la posición en el valor de renta variable 13F declarado por ese gestor — la medida de convicción. ✦ = gestor seleccionado.
Nuevos compradores
| Sin nuevos compradores rastreados este trimestre. |
Posición cerrada
| Sin salidas rastreadas este trimestre. |
Contexto de mercado completo: entre TODOS los filers 13F (datos estructurados SEC, Q1 2026): 135 tenedores, 108.23M acciones, $397.63M declarado. Este es un período diferente y anterior al de las cifras del universo rastreado que figuran arriba, y ambos nunca se mezclan.
Qué otros valores suelen tener también los tenedores rastreados de este activo — recuentos de cotenencia, no relaciones fundamentales.